Cargando…

Triptans and CGRP blockade – impact on the cranial vasculature

The trigeminovascular system plays a key role in the pathophysiology of migraine. The activation of the trigeminovascular system causes release of various neurotransmitters and neuropeptides, including serotonin and calcitonin gene-related peptide (CGRP), which modulate pain transmission and vascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benemei, Silvia, Cortese, Francesca, Labastida-Ramírez, Alejandro, Marchese, Francesca, Pellesi, Lanfranco, Romoli, Michele, Vollesen, Anne Luise, Lampl, Christian, Ashina, Messoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635141/ https://www.ncbi.nlm.nih.gov/pubmed/29019093 http://dx.doi.org/10.1186/s10194-017-0811-5

Ejemplares similares

Migraine and cluster headache – the common link
por: Vollesen, Anne Luise, et al.
Publicado: (2018)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
por: Deligianni, Christina, et al.
Publicado: (2023)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?
por: Pellesi, Lanfranco
Publicado: (2023)

Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study
por: Pellesi, Lanfranco, et al.
Publicado: (2022)

Spotlight on Anti‐CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
por: Pellesi, Lanfranco, et al.
Publicado: (2017)

Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
por: Do, Thien Phu, et al.
Publicado: (2023)

Reducing Episodic Cluster Headaches: Focus on Galcanezumab
por: Pellesi, Lanfranco, et al.
Publicado: (2020)

PACAP38 in human models of primary headaches
por: Ashina, Håkan, et al.
Publicado: (2017)

Effect of CGRP and sumatriptan on the BOLD response in visual cortex
por: Asghar, Mohammad S., et al.
Publicado: (2012)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
por: Kageneck, Charlotte, et al.
Publicado: (2014)

CGRP receptors and TRP channels in migraine
por: Geppetti, Pierangelo, et al.
Publicado: (2015)

Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity
por: Akerman, Simon, et al.
Publicado: (2019)

Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists
por: Huber, Carola A, et al.
Publicado: (2019)

The Effect of K(ATP) Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
por: Coskun, Hande, et al.
Publicado: (2021)

Mode and site of action of therapies targeting CGRP signaling
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2023)

All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)

Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001)

Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)

Success and failure of triptans
por: Saxena, Pramod R., et al.
Publicado: (2001)

Selecting the preferred triptans
por: McCrory, Douglas C., et al.
Publicado: (2004)

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial
por: Pellesi, Lanfranco, et al.
Publicado: (2021)

Facial pain and multiple cranial palsies in a patient with skin cancer
por: Viken, Janina, et al.
Publicado: (2011)

Non-invasive in situ visualization of the murine cranial vasculature
por: Rosenblum, Jared S., et al.
Publicado: (2022)

Best Value for Money in Triptans
por: Curtiss, Frederic R.
Publicado: (2005)

Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan
por: Milano, Giulia, et al.
Publicado: (2017)

Triptans and troponin: a case report
por: Weder, Claudia R, et al.
Publicado: (2009)

Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
por: Iannone, Luigi Francesco, et al.
Publicado: (2022)

Association between response to triptans and response to erenumab: real-life data
por: Frattale, Ilaria, et al.
Publicado: (2021)

Measurement precision and biological variation of cranial arteries using automated analysis of 3 T magnetic resonance angiography
por: Amin, Faisal Mohammad, et al.
Publicado: (2014)

Use of triptans for the control of headache in bacterial meningitis
por: Wiwanitkit, Viroj
Publicado: (2014)

Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016)

Calcitonin Gene-Related Peptide in Tension-Type Headache
por: Ashina, Messoud
Publicado: (2001)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Craniula: A cranial window technique for prolonged imaging of brain surface vasculature with simultaneous adjacent intracerebral injection
por: Zuluaga-Ramirez, Viviana, et al.
Publicado: (2015)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Triptans utilization in Italian population: A real-life study in community pharmacies
por: Baratta, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svlg1l8md876mldf24dlgho4r1